A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients

BACKGROUND: Hydromorphone is a standard opioid analgesic for cancer pain that, prior to this study, was not approved in Japan, where options for opioid switching are limited. We aimed to investigate the efficacy and safety of hydromorphone (DS-7113b) immediate-release tablets in opioid-naïve cancer...

Full description

Saved in:
Bibliographic Details
Published in:Jpn J Clin Oncol
Main Authors: Inoue, Satoshi, Saito, Yoji, Tsuneto, Satoru, Aruga, Etsuko, Takahashi, Hiroshi, Uemori, Mitsutoshi
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5974780/
https://ncbi.nlm.nih.gov/pubmed/29659913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyy038
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items